openPR Logo
Press release

Orthobiologics Market Major players are Stryker Corporation, Zimmer Biomet Holdings, Inc., Wright Medical Group, Inc., Integra LifeSciences Holdings Corporation, Arthrex, Inc. (Arthrex), Johnson and Johnson

03-22-2019 02:04 PM CET | Health & Medicine

Press release from: Allied Market Research

Orthobiologics Market Major players are Stryker Corporation,

According to a new report published by Allied Market Research, titled,"Orthobiologics Market by Product, Application, Type, and End User: Global Opportunity Analysis and Industry Forecast, 2018 - 2025,"the market was valued at $4,870 million in 2017, and is projected to reach $6,870 million by 2025, growing at a CAGR of 4.3% from 2018 to 2025.

Download the Sample Report @ https://www.alliedmarketresearch.com/request-sample/845?utm_source=openpr&utm_medium=Niranjan

Orthobiologics are substances that orthopedic surgeons utilize to help injuries heal more quickly. These products are made from substances that are naturally found in the human body. These are used to improve the healing of broken bones and injured muscles, tendons, and ligaments.

The key factors that drive the growth of the global orthobiologics market are an increased demand for advanced treatment and rise in prevalence of osteoarthritis, degenerative arthritis, spinal injuries, and soft tissue injuries majorly drive the growth of the market. Further, the rise in obesity rate, growth in awareness among the patients, and an increase in geriatric population support the market growth. However, the high cost of procedures and stringent regulatory approval process restrict the growth of this market. Advancements in implant technologies and growth in demand for biological solutions create opportunities for market growth.

The global orthobiologics market is segmented based on product, application, type, end user, and region. Based on product, the market is classified into demineralized bone matrix (DBM), allograft, bone morphogenetic protein (BMP), viscosupplementation products, synthetic bone substitutes, and others. Viscosupplementation products are the largest and fastest growing segment. This is due to its application for the treatment of knee pain associated with osteoarthritis. Increase in geriatric population, a rise in prevalence of osteoarthritis, and growth in lifestyle-induced disorders, such as obesity, drive the adoption of viscosupplement products.

For Purchase Inquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/845?utm_source=openpr&utm_medium=Niranjan

Based on the type, the market is categorized into the knee, ankle, hip, wrist & shoulder, spine, and others. The knee segment held the largest share in the market in 2017; this is due to the rise in the number of aged patients undergoing knee replacement procedures. A spine is a fastest growing segment due to the rise in the number of sports-related injuries to the spine.

Based on application, the market is categorized into an application such as osteoarthritis & degenerative arthritis, spinal fusion, fracture recovery, soft tissue injuries, maxillofacial, and dental applications. Osteoarthritis & degenerative arthritis is the largest segment due to the increase in the prevalence of these conditions. Spinal fusion was the fastest growing segment in 2017 owing to the benefits offered by orthobiologics in the treatment.

Based on the end user, the market is categorized into hospitals & ambulatory centers, research & academic institute, and dental clinics. The hospitals & ambulatory centers segment held the largest share in the market in 2017 and is the fastest growing segment as these facilities are fully equipped for performing the surgeries and have the skilled professionals to carry out the procedures.

Based on region, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Key Findings of the Orthobiologics Market:
• North America occupied more than half of the share of the global orthobiologics market in 2017.
• The spinal fusion segment is anticipated to grow with a CAGR of 4.9% during the forecast period.
• The knee segment accounted for more than one-third share of the market in 2017.
• Asia-pacific is anticipated to grow at the highest rate during the analysis period, followed by LAMEA.
• North America was the leading revenue contributor to the global market in 2017, garnering nearly more than half of the total market share, owing to high purchasing power.
• Rise in the elderly population, favorable reimbursement rates, increase in the prevalence of orthopedic disorders even among the younger population, and surge in the number of road & sports, However.
• Asia-Pacific is expected to grow at the highest CAGR of 5.7% from 2018 to 2025, owing to an increase in disposable income; surge in obesity, sports-related accidents; and rise in awareness related to different orthobiologics.

The report provides an extensive competitive analysis and profiles of the key market players such as Stryker Corporation, Zimmer Biomet Holdings, Inc., Wright Medical Group, Inc., Integra LifeSciences Holdings Corporation, Arthrex, Inc. (Arthrex), Johnson and Johnson (J&J), Exactec Inc., Medline Industries, Inc., Globus Medical, Inc., and NuVasive Inc.

3: MARKET OVERVIEW

3.1. Market definition and scope

3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.2.3. Porters five forces analysis

3.3. Market dynamics

3.3.1. Drivers
3.3.1.1. The rise in the incidence of orthopedic diseases & injury
3.3.1.2. Growth in the aging population
3.3.1.3. Increase in sports injuries

3.3.2. Restraints
3.3.2.1. The high cost of the orthobiologics product
3.3.2.2. Stringent approval process

3.3.3. Opportunity
3.3.3.1. Improvement in healthcare infrastructure

3.4. Top player positioning, 2017

About Us:-

Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact Us:-

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Orthobiologics Market Major players are Stryker Corporation, Zimmer Biomet Holdings, Inc., Wright Medical Group, Inc., Integra LifeSciences Holdings Corporation, Arthrex, Inc. (Arthrex), Johnson and Johnson here

News-ID: 1667569 • Views: 870

More Releases from Allied Market Research

North America Geogrid Market 2020 Segmentation, Demand, Growth, Trend, Opportuni …
According to the report published by Allied Market Research, the North America geogrid market generated $282.0 million in 2019, and is estimated to reach $408.25 million by 2027, registering a CAGR of 7.0% from 2020 to 2027. The report offers an extensive analysis of changing market dynamics, key winning strategies, business performance, major segments, and competitive scenarios. Surge in infrastructure development activities across the U.S. and Mexico and superior physical properties
Intravenous Immunoglobulin (IVIG) Market 2020 In-Depth Analysis of Industry Shar …
Global intravenous immunoglobulin market accounted for $8,995 million in 2017, and is projected to reach $15,964 million by 2025, registering a CAGR of 7.5% from 2018 to 2025. Immunoglobulin (Ig) is a plasma-derived product, which is obtained from the serum of healthy donors. The isolated plasma product is clinically treated and purified to Ig, which can be further used in the treatment of patients with antibody deficiency. Intravenous immunoglobulin (IVIG) finds
Asthma and COPD Drugs Market Is Expected to Witness a Steady Growth by 2026
"Asthma and COPD Drugs Market by Disease and Medication Class - Global Opportunity Analysis and Industry Forecasts, 2014-2022", projects that the global market for Asthma and COPD Drugs was valued at $38,960 million in 2015 and would reach $50,359 million by 2022, registering a CAGR of 3.7% from 2016 to 2022. Asthma segment dominated the market in 2015 and expected to continue its dominance throughout the forecast period. North America
Synthetic Biology Market in Global Industry by Top Companies, Type and Applicati …
Global Synthetic biology market is forecast to reach $38.7 billion by 2020, at a CAGR of 44.2% during the forecast period (2014 - 2020). Europe occupies largest share in the global market and would hold-on to its position throughout 2020. However, Asia Pacific is the fastest growing market with a CAGR of 46.4% from 2014 - 2020. Read Full Report @ https://www.alliedmarketresearch.com/synthetic-biology-market Synthetic biology is at a nascent stage and has recently

All 5 Releases


More Releases for Orthobiologics

Orthobiologics Market Objectives and Detailed Study 2018
WiseGuyReports.Com Publish a New Market Research Report On –“ Orthobiologics Market Objectives and Detailed Study 2018”. Description:- The Orthobiologics industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Orthobiologics market size to maintain the average annual growth rate of 3.04% from 4260 million $ in 2014 to 4660 million $ in 2017, The analysts believe that in the next few years, Orthobiologics
Global Orthobiologics Market $6.2 Billion by 2021
Orthobiologics Market Analysis and Forecast 2017-2021 report estimates the global orthobiologics market to reach nearly $6.2 Billion in 2021, at a CAGR of 6.2% from 2017 to 2021 - iHealthcareAnalyst, Inc. The global orthobiologics market report provides market size (Revenue $Million 2014 to 2021), market share and forecasts growth trends (CAGR%, 2017 to 2021). The global orthobiologics market segmentation is based on product types (allograft, bone morphogenetic proteins, demineralized bone matrix,
Orthobiologics Market Intelligence Report for Comprehensive Information
Biologic treatment has made a significant impact in orthopedic surgery, incorporating patient’s own cells, tissues, proteins produced artificially, etc. in the orthopedic treatment. The demand for global orthobiologics market is increasing due to the rise in aging population, changing lifestyles, problems associated with musculoskeletal system and developments in technologies. The global orthobiologics market is anticipated to grow with double digit growth rate over the forecast period with the demand for
Global Orthobiologics Sales Market Report 2017
In this report, the global Orthobiologics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. This report studies Orthobiologics in Global Sales market , especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with sales, price, revenue and market
Orthobiologics Market USD 5.8 Billion by 2020
Orthobiologics Market 2013-2020 report estimates the global orthobiologics market to reach nearly USD 5.8 Billion in 2020, at a CAGR of 6.2% from 2016 to 2020 - iHealthcareAnalyst, Inc. Visit the Orthobiologics Market 2013-2020 report https://www.ihealthcareanalyst.com/report/orthobiologics-market/ The global orthobiologics market report provides market size (Revenue USD Million 2013 to 2020), market share and forecasts growth trends (CAGR%, 2016 to 2020). The global orthobiologics market segmentation is based on product types (allograft, bone
Orthobiologics Market Forecast and Segments, 2015-2025
Biologic treatment has made a significant impact in orthopedic surgery, incorporating patient’s own cells, tissues, proteins produced artificially, etc. in the orthopedic treatment. The demand for global orthobiologics market is increasing due to the rise in aging population, changing lifestyles, problems associated with musculoskeletal system and developments in technologies. The global orthobiologics market is anticipated to grow with double digit growth rate over the forecast period with the demand for